Physician profile
Robert S Marsh
NPI 1306969738
$2,290.67
in general payments reported to CMS, 2019-2025
18 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.68 · 2020: $175 · 2021: $55.07 · 2022: $1,449 · 2023: $339 · 2024: $84.82 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,214.80 | 2021-2022 | |
| Stryker Corporation | $478.47 | 2019-2023 | Prophecy, Ortholoc 3di, Charlotte |
| Smith+Nephew, INC. | $95.00 | 2020-2025 | Cap-Fix, Ultrabutton |
| Depuy Synthes Sales INC. | $78.41 | 2022-2024 | Motoband, Na, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $62.68 | 2020-2023 | Gel-One Cross-Linked Hyaluronate |
| Restor3d, INC. | $56.67 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $51.29 | 2025 | |
| Organogenesis INC. | $43.46 | 2022-2024 | Novachor |
| In2bones USA, LLC | $42.42 | 2022 | |
| Polynovo North America LLC | $37.16 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $22.17 | 2025 | Zilretta, Iovera |
| Orthalign INC | $19.85 | 2023 | Orthalign Plus |
| Ferring Pharmaceuticals INC. | $18.66 | 2025 | Euflexxa |
| Wright Medical Technology, INC. | $17.49 | 2020 | |
| Mimedx Group, INC. | $14.46 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $14.28 | 2023 | |
| Sanofi-Aventis U.S. LLC | $11.93 | 2020 | |
| Baxter Healthcare | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.